Related Experiment Video
Updated: Jun 23, 2025

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
MAPK13 controls structural remodeling and disease after epithelial injury
Kangyun Wu1, Yong Zhang1, Dailing Mao1
1Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Mitogen-activated protein kinase 13 (MAPK13) controls structural remodeling after epithelial injury. Inhibiting MAPK13 in mice and human cells prevents disease progression, offering a new therapeutic target.
Area of Science:
- Cellular biology
- Molecular medicine
- Respiratory disease research
Background:
- Epithelial repair after injury can lead to structural remodeling and chronic disease.
- Understanding the molecular control of this divergence is crucial for disease modification.
- Stress kinases regulating epithelial stem cells are a potential target for intervention.
Purpose of the Study:
- To investigate the role of mitogen-activated protein kinase 13 (MAPK13) in regulating epithelial stem cells.
- To determine if MAPK13 controls structural remodeling and disease following respiratory viral injury.
- To explore MAPK13 as a potential therapeutic target for remodeling-associated lung diseases.
Main Methods:
- Utilized gene-knockout mouse models of respiratory viral injury.
- Examined MAPK13 regulation in basal-epithelial stem cells (basal-ESCs) using cell culture and organoid formation.
- Analyzed human clinical samples from asthma and COPD patients.
- Performed gene-knockdown experiments in human basal-ESCs.
Main Results:
- Mapk13-knockout mice were protected from structural remodeling, including basal-ESC hyperplasia-metaplasia, immune activation, and mucinous differentiation after injury.
- Mapk13 deficiency attenuated basal-ESC growth and organoid formation in cell models.
- Human basal cells showed increased MAPK13 activity in asthma and COPD samples.
- MAPK13 knockdown inhibited human basal-ESC growth in culture.
Conclusions:
- MAPK13 acts as a key regulator of structural remodeling and disease development after epithelial injury.
- Targeting MAPK13 for down-regulation presents a viable disease-modifying strategy for conditions like asthma and COPD.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Role of Matrix Metalloproteases in Degradation of ECM
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The JAK-STAT Signaling Pathway

